Bone Mineral Density in Iranian Adolescents and Young Adults with Beta-thalassemia Major
Overview
Authors
Affiliations
The authors investigated the prevalence of low bone mass in patients from Tehran, Iran, with beta-thalassemia major (n = 203), aged 10-20 years, and the potential risk factors for osteoporosis in this patient population. Prevalence of osteoporosis was 50.7% in lumbar spine, 10.8% in femur, and 7.9% in both regions with no significant difference between the two genders. The following factors were associated with low BMD: height for age and weight for age below 3rd percentile, delayed puberty or hypogonadism, age when Desferal (for iron chelation) was started, duration of Desferal therapy, and serum zinc. Low serum copper and 25(OH)D were not associated with low BMD.
Das L, Khadwal A, Malhotra P, Ghosh J, Dhiman V, Sharma V JBMR Plus. 2024; 8(11):ziae117.
PMID: 39372604 PMC: 11450324. DOI: 10.1093/jbmrpl/ziae117.
Treatment for osteoporosis in people with beta-thalassaemia.
Bhardwaj A, Swe K, Sinha N Cochrane Database Syst Rev. 2023; 5:CD010429.
PMID: 37159055 PMC: 10167785. DOI: 10.1002/14651858.CD010429.pub3.
Santra S, Sharma K, Dash I, Mondal S, Mondal H Cureus. 2022; 14(7):e26688.
PMID: 35959170 PMC: 9359209. DOI: 10.7759/cureus.26688.
Assessment of biochemical bone markers of osteoporosis in children with thalassemia major.
Celik T, Sangun O, Unal S, Balci A, Motor S Ital J Pediatr. 2022; 48(1):105.
PMID: 35725492 PMC: 9210807. DOI: 10.1186/s13052-022-01290-x.
Musculoskeletal imaging manifestations of beta-thalassemia.
Hajimoradi M, Haseli S, Abadi A, Chalian M Skeletal Radiol. 2021; 50(9):1749-1762.
PMID: 33559685 DOI: 10.1007/s00256-021-03732-9.